Publication:
Efficacy of plerixafor plus g-csf in patients with multiple myeloma and lymphoma who have had mobilization failure with at least two regimens. a retrospective study

dc.contributor.buuauthorÖzkocaman, V.
dc.contributor.buuauthorÖZKOCAMAN, VİLDAN
dc.contributor.buuauthorPınar, İbrahim Ethem
dc.contributor.buuauthorPINAR, İBRAHİM ETHEM
dc.contributor.buuauthorÖzkalemkas, Fahri
dc.contributor.buuauthorÖZKALEMKAŞ, FAHİR
dc.contributor.buuauthorErsal, Tuğba
dc.contributor.buuauthorERSAL, TUBA
dc.contributor.buuauthorBuldu, Merve
dc.contributor.buuauthorBULDU, MERVE
dc.contributor.buuauthorGürsoy,
dc.contributor.buuauthorGÜRSOY, VİLDAN
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi.
dc.contributor.orcid0000-0001-9907-1498
dc.contributor.orcid0000-0002-0116-2082
dc.contributor.researcheridJGM-6601-2023
dc.contributor.researcheridM-1070-2014
dc.contributor.researcheridJWP-2738-2024
dc.date.accessioned2024-09-26T10:46:14Z
dc.date.available2024-09-26T10:46:14Z
dc.date.issued2022-11-01
dc.descriptionBu çalışma, 19-23 Mart 2022 tarihleri arasında Çek Cumhuriyeti’de düzenlenen 48. Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)’da bildiri olarak sunulmuştur.
dc.description.sponsorshipEuropean Soc Blood & Marrow Transplantat
dc.identifier.endpage413
dc.identifier.issn0268-3369
dc.identifier.issueSUPPL 1, Supplement 1
dc.identifier.startpage412
dc.identifier.urihttps://hdl.handle.net/11452/45304
dc.identifier.volume57
dc.identifier.wos000878153300668
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherSpringernature
dc.relation.journalBone Marrow Transplantation
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectHematology
dc.subjectImmunology
dc.subjectTransplantation
dc.subjectBiophysics
dc.titleEfficacy of plerixafor plus g-csf in patients with multiple myeloma and lymphoma who have had mobilization failure with at least two regimens. a retrospective study
dc.typeMeeting Abstract
dspace.entity.typePublication
relation.isAuthorOfPublication516d4442-e436-45a6-87b9-741a9e213d31
relation.isAuthorOfPublication780690ec-9c57-47ed-a462-d5d676cd36e3
relation.isAuthorOfPublication6d4676a2-f825-4560-bfa8-c7eb6daf748d
relation.isAuthorOfPublication5ffc1973-3410-4bba-98b1-593db4259ac6
relation.isAuthorOfPublication87f29dbd-514d-4d75-85eb-07130a6a739d
relation.isAuthorOfPublication5314c279-faa2-434b-96f6-a170ad1221eb
relation.isAuthorOfPublication.latestForDiscovery516d4442-e436-45a6-87b9-741a9e213d31

Files

Collections